T-CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引：199
|
作者：
HALE, G
COBBOLD, S
WALDMANN, H
机构：
来源：
TRANSPLANTATION | 1988年 / 45卷 / 04期
关键词：
D O I：
10.1097/00007890-198804000-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：753 / 759
页数：7
相关论文
共 50 条
  • [41] T-CELL DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION - FUNCTIONAL T-CELL RECONSTITUTION IN THE EARLY PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION MEASURED BY LIMITING DILUTION ANALYSIS
    HOFFMANN, T
    THEOBALD, M
    BUNJES, D
    WIESNETH, M
    HERTENSTEIN, B
    HEIT, W
    BLUT, 1987, 55 (04): : 376 - 376
  • [42] QUANTITY AND NATURE OF RESIDUAL BONE-MARROW T-CELLS AFTER TREATMENT OF THE MARROW WITH CAMPATH-1
    IRLE, C
    KAESTLI, M
    AAPRO, M
    CHAPUIS, B
    JEANNET, M
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (02) : 163 - 170
  • [43] PREVENTION OF ACUTE GVHD IN ALLOGENEIC BONE-MARROW TRANSPLANTATION BY INVITRO TREATMENT WITH THE MONOCLONAL ANTI-LYMPHOCYTE ANTIBODY CAMPATH-1
    WIESNETH, M
    BUNJES, D
    ARNOLD, R
    SCHMEISER, T
    HALE, G
    HEIMPEL, H
    HEIT, W
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 146 - 146
  • [44] THE INFLUENCE OF T-CELL DEPLETION ON THE OCCURRENCE OF INFECTIONS AFTER BONE-MARROW TRANSPLANTATION
    SCHMEISER, T
    KURRLE, E
    ARNOLD, R
    WIESNETH, M
    BUNJES, D
    HEIMPEL, H
    HEIT, W
    BLUT, 1986, 53 (03): : 199 - 200
  • [45] OPTIMAL CONDITIONS FOR INVITRO T-CELL DEPLETION OF HUMAN-BONE MARROW BY CAMPATH-1 PLUS COMPLEMENT AS DEMONSTRATED BY LIMITING DILUTION ANALYSIS
    FRAME, JN
    SHEEHY, D
    CARTAGENA, T
    CIRRINCIONE, C
    OREILLY, RJ
    DUPONT, B
    KERNAN, NA
    BONE MARROW TRANSPLANTATION, 1989, 4 (01) : 55 - 61
  • [46] BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA - T-CELL DEPLETION WITH CAMPATH-1 REDUCES THE INCIDENCE OF GRAFT-VERSUS-HOST DISEASE BUT MAY INCREASE THE RISK OF LEUKEMIC RELAPSE
    APPERLEY, JF
    JONES, L
    HALE, G
    WALDMANN, H
    HOWS, J
    ROMBOS, Y
    TSATALAS, C
    MARCUS, RE
    GOOLDEN, AWG
    GORDONSMITH, EC
    CATOVSKY, D
    GALTON, DAG
    GOLDMAN, JM
    BONE MARROW TRANSPLANTATION, 1986, 1 (01) : 53 - 66
  • [47] BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA - T-CELL DEPLETION WITH CAMPATH-1 REDUCES THE INCIDENCE OF GRAFT-VERSUS-HOST DISEASE BUT MAY INCREASE THE RISK OF LEUKEMIC RELAPSE
    GOLDMAN, JM
    APPERLEY, JF
    JONES, L
    HALE, G
    WALDMANN, H
    HOWS, J
    ROMBOS, Y
    TSATALAS, C
    MARCUS, RE
    GOOLDEN, AWG
    GORDONSMITH, EC
    CATOVSKY, D
    GALTON, DAG
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 447 - 447
  • [48] INFLUENCE OF CAMPATH-1 ON T-CELL AND NK-CELL
    SCHOFER, O
    VEIT, BC
    JOHNSON, FL
    IMMUNITAT UND INFEKTION, 1988, 16 (04): : 143 - 147
  • [49] LEUKEMIC RELAPSE ASSOCIATED WITH PHENOTYPIC CHANGE AFTER CAMPATH-1 PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    POYNTON, CH
    SHAW, PJ
    BARRETT, AJ
    LANCET, 1986, 1 (8473): : 162 - 162
  • [50] CAMPATH-1 KILLS ADDITIONAL BONE-MARROW CELL-POPULATIONS WHEN EMPLOYED WITH HIGHER LYTIC ACTIVITY - IMPLICATIONS FOR CLINICAL T-DEPLETION
    MULLER, B
    KLICKER, G
    DREGER, P
    MULLERRUCHHOLTZ, W
    BLUT, 1987, 55 (04): : 373 - 373
12345